| Members |
targetComponentId |
| Urine protein (& level) |
Measurement of protein in urine (procedure) |
| Urine protein |
Protein |
| Urine protein electrop. NOS |
Urine protein electrophoresis |
| Urine protein electrop. NOS |
Urine protein electrophoresis |
| Urine reducing substances NOS |
Reducing substances detected in urine (finding) |
| Urine reducing substances NOS |
Reducing substances detected in urine (finding) |
| Urine volume |
Urine volume measurement finding (finding) |
| Urobilinogenemia |
Urobilinogen level above reference range (finding) |
| Urofollitrophin 150units powder and solvent for injection solution ampule |
Product containing only urofollitropin (medicinal product) |
| Urofollitrophin 150units powder for conventional release solution for injection ampule |
Product containing only urofollitropin (medicinal product) |
| Urofollitropin 75iu powder and solvent for injection solution ampule |
Product containing only urofollitropin (medicinal product) |
| Urofollitropin 75iu powder for conventional release solution for injection ampule |
Product containing only urofollitropin (medicinal product) |
| Urofollitropin 75iu powder for injection solution ampule |
Urofollitropin 150 unit/mL solution for injection |
| Urokinase 250000iu powder for injection solution vial |
Product containing only urokinase (medicinal product) |
| Urokinase 50000units/mL injection solution vial |
Urokinase 50000 unit/mL solution for injection |
| Uroporphyrinogen synthase |
Hydroxymethylbilane synthase |
| Uroporphyrinogen-1 synthase |
Hydroxymethylbilane synthase |
| Urticaria pigmentosa |
Cutaneous mastocytosis (disorder) |
| Urticaria pigmentosa |
Cutaneous mastocytosis (disorder) |
| Urticaria pigmentosa |
Cutaneous mastocytosis (morphologic abnormality) |
| Urticaria pigmentosa, diffuse erythrodermic type |
Diffuse erythrodermic mastocytosis (disorder) |
| Urticaria pigmentosa, maculopapular type |
Cutaneous mastocytosis (disorder) |
| Urticaria pigmentosa, multiple nodules AND/OR plaques |
Cutaneous mastocytosis (disorder) |
| Urticaria pigmentosa, solitary cutaneous nodule |
Solitary cutaneous mastocytoma (disorder) |
| Urticaria pigmentosa, telangiectasia macularis eruptiva perstans |
Telangiectasia macularis eruptiva perstans |
| Uses prostitutes |
Client of prostitutes |
| Using interatrial baffle |
Repair - action |
| Ustekinumab 90mg/mL injection solution |
Product containing only ustekinumab (medicinal product) |
| Uterine cervix TNM finding |
American Joint Committee on Cancer allowable value |
| Uterine incoordination |
Dyscoordinate labor |
| Uterine scar from previous surgery in pregnancy, childbirth and the puerperium with antenatal problem |
Uterine scar from previous surgery affecting pregnancy |
| Uveal melanoma TNM finding |
American Joint Committee on Cancer allowable value |
| V - volt |
volt (qualifier value) |
| V-Y operation for ectropion |
Repair of ectropion of skin of eyelid using local V-Y advancement flap (procedure) |
| V-Y operation of lip |
Reconstruction of skin of lip using local V-Y advancement flap |
| V-Y operation of skin and subcutaneous tissue without skin graft |
Reconstruction of skin using local V-Y advancement flap (procedure) |
| Vabra curette |
Curette |
| Vaccination required |
Requires vaccination (finding) |
| Vaccination required |
Requires vaccination (finding) |
| Vaccine product containing Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product) |
COVID-19 vaccine |
| Vaccine product containing only Human papillomavirus 9 antigen (medicinal product) |
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
| Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (medicinal product) |
Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product) |
| Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form) |
Inactivated whole Human poliovirus antigen only vaccine product |
| Vacuum delivery NOS |
Delivery by vacuum extraction |
| Vagal bradycardia |
Vagal autonomic bradycardia |
| Vagina TNM finding |
American Joint Committee on Cancer allowable value |
| Vaginal disorder NOS |
Disorder of vagina |
| Vaginal disorder NOS |
Disorder of vagina |
| Vaginal operation to support outlet of female bladder NOS |
Surgical procedure on outlet of urinary bladder (procedure) |
| Vaginal operations to support outlet of female bladder |
Surgical procedure on outlet of urinary bladder (procedure) |
| Vaginal outlet |
Vaginal introitus structure |
| Vaginal repair: [NOS] or [Fothergill] |
Manchester-Fothergill operation on uterus |
| Vaginal ulcertion |
Vaginal ulcer |
| Valacyclovir hydrochloride 1g caplet |
Valaciclovir (as valaciclovir hydrochloride) 1 g oral tablet |
| Valganciclovir 50mg/mL powder for oral solution |
Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Valproate sodium 100mg/mL solution for injection |
Product containing precisely valproic acid 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Valproate sodium 250mg/5mL syrup |
Valproic acid 50 mg/mL oral solution |
| Valproate sodium 500mg powder for injection solution vial |
Valproic acid only product in parenteral dose form |
| Valproic acid 250mg/5mL syrup |
Valproic acid 50 mg/mL oral solution |
| Vancomycin 1g solution |
Product containing only vancomycin (medicinal product) |
| Vancomycin hydrochloride 10g powder for infusion solution vial |
Product containing precisely vancomycin (as vancomycin hydrochloride) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Vancomycin hydrochloride 1g/bot powder |
Product containing only vancomycin (medicinal product) |
| Vancomycin hydrochloride 500mg injection |
Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Vancomycin hydrochloride 750mg powder for infusion solution |
Vancomycin only product in parenteral dose form |
| Vardenafil hydrochloride 10 mg tablet |
Vardenafil (as vardenafil hydrochloride) 10 mg oral tablet |
| Vardenafil hydrochloride 10mg orodispersible tablet |
Vardenafil (as vardenafil hydrochloride) 10 mg orodispersible tablet |
| Vardenafil hydrochloride 2.5 mg tablet |
Vardenafil (as vardenafil hydrochloride) 2.5 mg oral tablet |
| Vardenafil hydrochloride 20 mg tablet |
Product containing precisely vardenafil (as vardenafil hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) |
| Vardenafil hydrochloride 5 mg tablet |
Vardenafil (as vardenafil hydrochloride) 5 mg oral tablet |
| Varicella-zoster immune globulin 125 iu powder for injection solution vial |
Varicella-zoster virus antibody 104 unit/mL solution for injection |
| Varicose vein operation NOS |
Varicose vein operation |
| Varicose vein operation NOS |
Varicose vein operation |
| Varicose veins NOS |
Venous varices |
| Varicose veins NOS |
Venous varices |
| Varicose veins NOS |
Venous varices |
| Vas deferens operation NOS |
Operation on vas deferens |
| Vas deferens operation NOS |
Operation on vas deferens |
| Vascular access incision |
Incision |
| Vascular disorder of iris AND/OR ciliary body |
Disorder of uveal tract |
| Vascular lesions of cord with antenatal problem |
Vascular lesion of cord |
| Vascular procedures on axilla |
Vascular procedure on axilla (procedure) |
| Vascularized rib flap |
Bone flap |
| Vasodilator antihypertensive drug allergy |
Allergy to drug |
| Vasopressin 20unt/mL injection |
Antidiuretic hormone 20 unit/mL solution for injection |
| Vasopressin 20unt/mL injection solution 0.5mL vial |
Antidiuretic hormone 20 unit/mL solution for injection |
| Vasopressin 20unt/mL injection solution 10mL vial |
Antidiuretic hormone 20 unit/mL solution for injection |
| Vasopressin 20unt/mL injection solution 1mL vial |
Antidiuretic hormone 20 unit/mL solution for injection |
| Vasorrhaphy |
Suture of laceration of vas deferens |
| Vatican City |
Holy See |
| Vectorcardiogram with ECG |
Electrocardiogram with vectorcardiogram |
| Vecuronium bromide 4mg powder for injection solution vial |
Product containing only vecuronium in parenteral dose form (medicinal product form) |
| Veillonella alcalescens |
Veillonella parvula (organism) |
| Veillonella alcalescens ss alcalescens |
Veillonella parvula (organism) |
| Veillonella alcalescens ss criceti |
Veillonella criceti |
| Veillonella alcalescens ss dispar |
Veillonella dispar |
| Veillonella alcalescens ss ratii |
Veillonella ratti |
| Velaglucerase alfa 200unit lyophilized powder for injection solution |
Product containing only velaglucerase alfa (medicinal product) |
| Velopharyngeal incompetence due to cleft palate |
Incomplete closure of velopharyngeal apparatus due to cleft palate |
| Velvet tobacco mottle virus group (Plant hosts) |
Velvet tobacco mottle virus |
| Venlafaxine hydrochloride 37.5mg m/r capsule |
Venlafaxine only product in oral dose form |
| Venlafaxine hydrochloride 37.5mg prolonged-release oral capsule |
Venlafaxine only product in oral dose form |
FHIR